Suscribirse

Diffusion-weighted MRI and PET/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy - 23/09/21

Doi : 10.1016/j.diii.2021.05.007 
Amandine Crombé a, b, c, , Lisa Gauquelin d, Stéphanie Nougaret e, Marine Chicart f, Marina Pulido d, Anne Floquet g, Frédéric Guyon h, Sabrina Croce i, Michèle Kind a, Anne-Laure Cazeau f
a Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
b Bordeaux University, 33000 Bordeaux, France 
c Modelisation in Oncology (MOnc) Team, INRIA Bordeaux-Sud-Ouest, CNRS UMR 5251, 33405, Talence, France 
d Department of Biostatistics, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
e Department of Radiology, Montpellier Cancer Institute, University of Montpellier, 34090 Montpellier, France 
f Department of nuclear medicine, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
g Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
h Department of Oncological Surgery, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 
i Department of Pathology, Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, 33000 Bordeaux, France 

Corresponding author at: Institut Bergonié, Comprehensive Cancer Center of Nouvelle-Aquitaine, Bordeaux 33000, France.Institut Bergonié, Comprehensive Cancer Center of Nouvelle-AquitaineBordeaux33000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Visual assessment of MRI and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography shows high inter- and intra-observer agreements on baseline examinations.
SUV-max, SUL-peak, SUV-mean at baseline and their changes show at least good reproducibility.
The measurement used and the evaluation time significantly influence the reproducibility.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

To investigate the reproducibility of diffusion-weighted (DW) MRI and 18F-Fluorodeoxyglucose (18F-FDG)-Positron emission tomography/CT (PET/CT) in monitoring response to neoadjuvant chemotherapy in epithelial ovarian cancer.

Materials and methods

Ten women (median age, 67 years; range: 41.8–77.3 years) with stage IIIC-IV epithelial ovarian cancers were included in this prospective trial (NCT02792959) between 2014 and 2016. All underwent initial laparoscopic staging, four cycles of carboplatine-paclitaxel-based chemotherapy and interval debulking surgery. PET/CT and DW-MRI were performed at baseline (C0), after one cycle (C1) and before surgery (C4). Two nuclear physicians and two radiologists assessed five anatomic sites for the presence of ≥1 lesion. Target lesions in each site were defined and their apparent diffusion coefficient (ADC), maximal standardized uptake value (SUV-max), SUV-mean, SUL-peak, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were monitored (i.e., 10 patients ×5 sites ×3 time-points). Their relative early and late changes were calculated. Intra/inter-observer reproducibilities of qualitative and quantitative analysis were estimated with Kappa and intra-class correlation coefficients (ICCs).

Results

For both modalities, inter- and intra-observer agreement percentages were excellent for initial staging but declined later for DW-MRI, leading to lower Kappa values for inter- and intra-observer variability (0.949 and 1 at C0, vs. 0.633 and 0.643 at C4, respectively) while Kappa values remained>0.8 for PET/CT. Inter- and intra-observer ICCs were>0.75 for SUV-max, SUL-peak, SUV-mean and their change regardless the time-point. ADC showed lower ICCs (range: 0.013–0.811). ANOVA found significant influences of the evaluation time, the measurement used (ADC, SUV-max, SUV-mean, SUV-max, SUL-peak, MTV or TLG) and their interaction on ICC values (P=0.0023, P<0.0001 and P =0.0028, respectively).

Conclusion

While both modalities demonstrated high reproducibility at baseline, only SUV-max, SUL-peak, SUV-mean and their changes maintained high reproducibility during chemotherapy.

El texto completo de este artículo está disponible en PDF.

Keywords : Carcinoma, Ovarian epithelial, Diffusion-weighted magnetic resonance imaging, Positron-emission tomography/Computed tomography, Reproducibility of results, Biomarkers, Tumors

Abbreviations : 18F-FDG, ADC, ANOVA, C0, C1, C4, CE, CI, dC0C1, dC0C4, DWI, ICC, LOA, MTV, PCI, PET/CT, ROI, SD, SUL-peak, SUV-max, SUV-mean, TLG


Esquema


© 2021  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 102 - N° 10

P. 629-639 - octobre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Intracranial venous sinus stenting for the treatment of lateral sinus stenoses: An analysis of 200 patients
  • Marc-Antoine Labeyrie, Matteo Fantoni, Ursula Vever, Alexis Guedon, Sophie Bonnin, Anne-Laure Bernat, Benjamin Verillaud, Emmanuel Houdart
| Artículo siguiente Artículo siguiente
  • Reduced nontarget embolization and increased targeted delivery with a reflux-control microcatheter in a swine model
  • Silvia Rizzitelli, Nir Holtzman, Geert Maleux, Thierry De Baere, Fei Sun, Pierre-Olivier Comby, Michael Tal, Gwenaelle Bazin, Francois Montestruc, Thomas Viel, Philippe Robert, Osnat Harbater, Eran Miller, Claire Corot

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.